Login / Signup

Targeted Degradation of Protein Kinase A via a Stapled Peptide PROTAC.

Matthew K WhittakerGeorge N BendzunasMahsa ShiraniTimothy J LeClairBassem SheblTaylor C DillPhilip CoffinoSanford M SimonEileen J Kennedy
Published in: ACS chemical biology (2024)
Proteolysis-targeting chimeras (PROTACs) are bifunctional molecules that bind and recruit an E3 ubiquitin ligase to a targeted protein of interest, often through the utilization of a small molecule inhibitor. To expand the possible range of kinase targets that can be degraded by PROTACs, we sought to develop a PROTAC utilizing a hydrocarbon-stapled peptide as the targeting agent to bind the surface of a target protein of interest. In this study, we describe the development of a proteolysis-targeting chimera, dubbed St apled I nhibitor P eptide - PRO TAC or StIP-TAC, linking a hydrocarbon-stapled peptide with an E3 ligase ligand for targeted degradation of Protein Kinase A (PKA). This StIP-TAC molecule stimulated E3-mediated protein degradation of PKA, and this effect could be reversed by the addition of the proteasomal inhibitor MG-132. Further, StIP-TAC treatment led to a significant reduction in PKA substrate phosphorylation. Since many protein targets of interest lack structural features that make them amenable to small molecule targeting, development of StIP-TACs may broaden the potential range of protein targets using a PROTAC-mediated proteasomal degradation approach.
Keyphrases
  • small molecule
  • protein protein
  • cancer therapy
  • protein kinase
  • amino acid
  • binding protein
  • drug delivery
  • tyrosine kinase
  • risk assessment
  • climate change
  • replacement therapy